Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.99 Analyst target: $22.00 Upside: 1005.53%
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.